Previous Close
$15.7
Day Range
$ - $
Previous Day Range
$ - $
Market Cap
$1.4 billion USD
Day Vol.
Previous Day Vol.
Currency
USD
Primary Exchange
New York Stock Exchange
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to...
Community
- 0 posts discussing
0
Watchers
0
Visitors